当期报告「修正」
Forte Biosciences(FBRX)02-17 05:25
$Forte Biosciences(FBRX)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001193125-24-038496 Act: 34 Size: 153 KB 网页链接
简介:Forte Biosciences, Inc.是一家临床阶段的皮肤病学公司,致力于开发用于治疗炎症性皮肤病的活体生物疗法FB-401。 FB-401已完成对成人和儿童(3岁及以上)特应性皮炎患者的1/2a期测试。 对于安全和有效的疗法,特别是对于小儿特应性皮炎患者,存在大量的需求。Forte计划在2020年代中期将FB-401推进到2期临床试验中。
今开:0.7399 | 昨收:0.739 |
最高:0.74 | 最低:0.71 |
涨停价: | 跌停价: |
总市值:26069654 |
Forte Biosciences(FBRX)02-17 05:25
$Forte Biosciences(FBRX)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001193125-24-038496 Act: 34 Size: 153 KB 网页链接
Forte Biosciences(FBRX)03-19 04:25
$Forte Biosciences(FBRX)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-24-070158 Act: 34 Size: 9 MB 网页链接
Forte Biosciences(FBRX)02-15 05:15
$Forte Biosciences(FBRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-036207 Act: 34 Size: 47 KB 网页链接
Forte Biosciences(FBRX)02-14 22:35
$Forte Biosciences(FBRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000908834-24-000082 Act: 34 Size: 451 KB 网页链接
Forte Biosciences(FBRX)03-26 04:15
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009032 Size: 5 KB 网页链接
Forte Biosciences(FBRX)02-15 06:05
$Forte Biosciences(FBRX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-036497 Act: 34 Size: 67 KB 网页链接
Forte Biosciences(FBRX)02-15 06:05
$Forte Biosciences(FBRX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000716 Act: 34 Size: 113 KB 网页链接
Forte Biosciences(FBRX)04-03 06:35
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009857 Size: 9 KB 网页链接
Forte Biosciences(FBRX)03-26 04:15
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009031 Size: 6 KB 网页链接
Forte Biosciences(FBRX)03-26 04:15
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009030 Size: 6 KB 网页链接
牛唐2022-08-25 16:18
有毒的壳公司:
借壳TOCA上市的$Forte Biosciences(FBRX)$ 又研发失败了,最近公司股东Funicular Funds认为董事会未能解决股东此前提出的合理担忧,决定走上一条价值毁灭性、焦土化的道路,进行不必要的融资,而对其行为没有任何解释。
$法拉第未来(FFIE)$ $网易(NTES)$查看全文
张512022-01-28 00:55
$Forte Biosciences(FBRX)$ 坑太多了,以后再也不买小公司的股票了查看全文
仓总麦飞之我还在2021-09-04 12:09
$Forte Biosciences(FBRX)$ 入仓机会来了,加油查看全文
牛唐2021-09-03 21:42
牛唐2021-09-03 17:33
$Forte Biosciences(FBRX)$ 精准清仓,躲开暴跌。$阿里巴巴(BABA)$ $理想汽车(LI)$查看全文
chuminhua2021-09-03 17:00
9月2日,Forte Biosciences公司的股票周四下跌了85%,因为该公司报告说其用于治疗特应性皮炎的外用活生物疗法FB-401未能达到II期研究的主要终点。鉴于这一结果,该公司将不再继续推进FB-401。
据Forte Bio公司称,FB-401由三种治疗性革兰氏阴性细菌Roseomonas mucosa菌株组成,这些菌株因其对...查看全文
产业链观察2021-09-03 04:53
药闻| 2021年9月2日,$Forte Biosciences(FBRX)$ 今天宣布其用于治疗特应性皮炎的FB-401第二阶段临床试验的顶级数据未能达到EASI-50主要终点的统计学意义(根据EASI衡量,特应性皮炎疾病严重程度至少改善50%的患者比例)。
盘后公司股价跳水跌85%查看全文
同写意2021-07-27 20:18
仗剑行天涯2021-05-20 13:57
$冠昊生物(SZ300238)$ 作为冠昊的股东,我和许多股友一样,也非常关注本维莫德湿疹/特应性皮炎的3期临床进度。本文旨在做一个简单的梳理分析,以及表达一下个人对公司的期望。
一、湿疹临床回顾
首先,想必大家都应知道,一个药品从研发、临床试验到上市本就是一个长周期的事,对一款全球...查看全文
$Forte Biosciences(FBRX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-094625 Act: 33 Size: 88 KB 网页链接
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009857 Size: 9 KB 网页链接
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009859 Size: 9 KB 网页链接
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009030 Size: 6 KB 网页链接
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009031 Size: 6 KB 网页链接
$Forte Biosciences(FBRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009032 Size: 5 KB 网页链接
$Forte Biosciences(FBRX)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-24-070158 Act: 34 Size: 9 MB 网页链接
$Forte Biosciences(FBRX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-032843 Act: 34 Size: 8 MB 网页链接
$Forte Biosciences(FBRX)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001193125-24-038496 Act: 34 Size: 153 KB 网页链接
$Forte Biosciences(FBRX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000716 Act: 34 Size: 113 KB 网页链接